NuVasive, Medtronic settle litigation
This article was originally published in The Gray Sheet
Firms resolve all legal action related to Medtronic's assertion that NuVasive interfered with non-competition and confidentiality agreements by hiring three former Sofamor Danek employees, a Nov. 15 release says. All outstanding lawsuits have been dismissed with prejudice and the parties are keeping the terms of the resolution confidential, according to NuVasive. Medtronic first sued the San Diego firm in 2001 (1"The Gray Sheet" March 15, 2004, p. 22). NuVasive, which plans to enter the artificial disc market with its Maximum Access Surgery system, recently completed an IPO to raise funds to develop injectable disc nucleus replacement materials and total lumbar disc products...
You may also be interested in...
NuVasive plans to use proceeds from its initial public offering to develop injectable disc nucleus replacement materials and total lumbar disc products
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.